Amplifon SpAFRA:AXNA -0.20%74 PB Ratio is 2.04 as of Jun. 26, 2026, which is 67% below its 10-year median of 6.19. GuruFocus rates FRA:AXNA with a GF Score™ of 74/100 and a GF Value™ of €25.67 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 112 Medical Distribution companies, Amplifon SpA ranks worse than 70.54% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Amplifon SpA's share price is €9.964. Amplifon SpA's Book Value per Share for the quarter that ended in Mar. 2026 was €4.89. Hence, Amplifon SpA's PB Ratio of today is 2.04.
The historical rank and industry rank for Amplifon SpA's PB Ratio or its related term are showing as below:
FRA:AXNA'
s PB Ratio Range Over the Past 10 Years
Min: 1.84 Med: 6.19 Max: 12.31
Current: 2.12
During the past 13 years, Amplifon SpA's highest PB Ratio was 12.31. The lowest was 1.84. And the median was 6.19.
FRA:AXNA's PB Ratio is ranked worse than 70.54% of 112
companies
in the Medical Distribution industry
Industry Median: 1.03
vs FRA:AXNA: 2.12
During the past 12 months, Amplifon SpA's average Book Value Per Share Growth Rate was -3.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -0.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 5.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 8.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Amplifon SpA was 24.00% per year. The lowest was -7.10% per year. And the median was 9.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Amplifon SpA PB Ratio Related Terms
Amplifon SpA PB Ratio Historical Data
* Premium members only.
The historical data trend for Amplifon SpA's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Amplifon SpA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplifon SpA PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amplifon SpA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Amplifon SpA's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Amplifon SpA's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Amplifon SpA (FRA:AXNA) has a PB Ratio of 2.04 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Amplifon SpA and its competitors. This is 67% below median its historical median of 6.19. Over the past decade, Amplifon SpA's PB Ratio has ranged from 1.84 to 12.31. According to the industry distribution chart, Amplifon SpA ranks #79 out of 112 companies in the Medical Distribution industry, placing it in the top 70.5%.
Is Amplifon SpA's PB Ratio too high?
Amplifon SpA's current PB Ratio of 2.04 is 67% below median its 10-year median of 6.19. Over the past 10 years, this metric has ranged from a low of 1.84 to a high of 12.31. The Medical Distribution industry median PB Ratio is 1.03. Amplifon SpA's value of 2.04 is 98.1% above this industry median. Based on the distribution chart, Amplifon SpA ranks #79 out of 112 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Amplifon SpA has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Amplifon SpA's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amplifon SpA ranks #79 out of 112 companies for PB Ratio. This places Amplifon SpA in the lower half of its industry. The industry median PB Ratio is 1.03. Amplifon SpA's value of 2.04 is 98.1% above this benchmark. Historically, Amplifon SpA's own PB Ratio has ranged from 1.84 to 12.31 over the past decade. While the company's 10-year median is 6.19 vs. the industry median of 1.03, Amplifon SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.03, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amplifon SpA's current PB Ratio of 2.04 is 98.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Amplifon SpA and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amplifon SpA's current PB Ratio is 2.04, which is 67% below median its own 10-year median of 6.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amplifon SpA stock overvalued right now?
Based on GuruFocus' analysis, Amplifon SpA (FRA:AXNA) is currently considered Possible Value Trap. The stock's GF Value™ is €25.67, compared to a current price of €9.96 — trading 61.2% below its estimated fair value. The current PB Ratio is 2.04, which is 67% below median its 10-year median of 6.19 and 98.1% above the Medical Distribution industry median of 1.03. Amplifon SpA's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Amplifon SpA (FRA:AXNA), the current PB Ratio is 2.04 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amplifon SpA (FRA:AXNA) Overvalued in 2026?
Based on GuruFocus' analysis, Amplifon SpA stock appears to be undervalued.
The current stock price of €9.96 is trading 61.2% below its estimated GF Value™ of €25.67.
GuruFocus considers Amplifon SpA to be Possible Value Trap.
Key valuation signals for FRA:AXNA:
PB Ratio: 2.04 (67% below median its 10-year median of 6.19)
GF Value™: €25.67 vs. price of €9.96 (61.2% below fair value)
Industry Position: 98.1% above the Medical Distribution median (#79 of 112)
No single metric tells the full story. See the FRA:AXNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.
74GF Score
Get the complete analysis for FRA:AXNA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AXNA has been successfully added to your 
